Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Metadata
Title
Some Aspects of the Cost of Schizophrenia in France
Publication date
01-06-1997
Published in
PharmacoEconomics / Issue 6/1997
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-199711060-00006

Other articles of this Issue 6/1997

PharmacoEconomics 6/1997 Go to the issue

Correspondence

Cost Effectiveness and Allocation of Therapies in a Treating Population: The Author’s Reply

Review Article

Constraints on Antidepressant Prescribing and Principles of Cost-Effective Antidepressant Use

Correspondence

Pre-Hospital Thrombolysis: The Author’s Reply

Correspondence

Cost Effectiveness and Allocation of Therapies in a Treating Population

Original Research Article

Cost-Benefit Analysis of Prophylactic Granulocyte Colony-Stimulating Factor During CHOP Antineoplastic Therapy for Non-Hodgkin’s Lymphoma

Original Research Article

Incremental Cost-Effectiveness Ratio of Alteplase in Patients with Acute Myocardial Infarction in the French Setting